A recent study from Peter Greer’s lab (Cancer Biology & Genetics, QCRI) has been published in Cancer Research Communications.
This collaborative work shows that targeting the adaptor protein Ezrin can improve chemotherapy response and reduce metastasis in preclinical breast cancer models.
This paper builds on longterm collaborations (Bruce Elliott, Sonal Verma and Chris Nicol), and was supported by Canadian Cancer Society, CIHR & MITACs). Read all about it here:
Dr. Feilotter and team are committed to advancing research and development that will improve the lives of Canadian cancer patients. Read more here
QCRI recently hosted the executive team from Ontario Institute for Cancer Research (OICR) on May 24th. This event showcased cutting edge research at QCRI/OICR and identified opportunities to expand partnerships. Thanks to all presenters and participants for such an engaging day discussing ongoing cancer research.
QCRI is excited to host a record number of summer studentships via the Craig Jury Memorial Summer Studentship & Weaver fund competitions.